Circulating angiotensin ii deteriorates left ventricular function with sympathoexcitation via brain angiotensin ii receptor

Physiological Reports

Volumn 3, Issue 8, 2015, Pages

  Shinohara, Keisuke ^a   Kishi, Takuya ^a   Hirooka, Yoshitaka ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Heart failure; Sympathetic nerve activity

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; GANGLION BLOCKING AGENT; HEXAMETHONIUM; HYDRALAZINE; LOSARTAN; NORADRENALIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL COMPLIANCE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG CONGESTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; RADIOIMMUNOASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPATHETIC INNERVATION; SYSTOLIC BLOOD PRESSURE;

EID: 85006070093     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12514     Document Type: Article

References (65)

1. Allen, A. M., J. K. Dosanjh, M. Erac, S. Dassanayake, R. D. Hannan, and W. G. Thomas. 2006. Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure. Hypertension 47:1054-1061
2. Bains, J. S., and A. V. Ferguson. 1995. Paraventricular nucleus neurons projecting to the spinal cord receive excitatory input from the subfornical organ. Am. J. Physiol. 268:R625-R633
3. Campese, V. M., Y. Shaohua, and Z. Huiquin. 2005. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46:533-539
4. Cato, M. J., and G. M. Toney. 2005. Angiotensin II excites paraventricular nucleus neurons that innervate the rostral ventrolateral medulla: an in vitro patch-clamp study in brain slices. J. Neurophysiol. 93:403-413
5. Chan, S. H., K. S. Hsu, C. C. Huang, L. L. Wang, C. C. Ou, and J. Y. Chan. 2005. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ. Res. 97:772-780
6. Cohn, J. N., T. B. Levine, M. T. Olivari, V. Garberg, D. Lura, G. S. Francis, et al. 1984. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311:819-823
7. Dampney, R. A. L. 1994. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 74:323-364
8. Engelhardt, S., L. Hein, F. Wiesmann, and M. J. Lohse. 1999. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 96:7059-7064
9. Esler, M. 2010. The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J. Appl. Physiol (1985) 108:227-237
10. Ferguson, A. V. 2009. Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology 89:370-376
11. Ferguson, D. W., W. J. Berg, and J. S. Sanders. 1990. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J. Am. Coll. Cardiol. 16:1125-1134
12. Florea, V. G., and J. N. Cohn. 2014. The autonomic nervous system and heart failure. Circ. Res. 114:1815-1826
13. Gaasch, W. H., and M. R. Zile. 2004. Left ventricular diastolic dysfunction and diastolic heart failure. Annu. Rev. Med. 55:373-394
14. Gao, L., W. Wang, Y. L. Li, H. D. Schultz, D. Liu, K. G. Cornish, et al. 2004. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ. Res. 95:937-944
15. Gao, L., W. Z. Wang, W. Wang, and I. H. Zucker. 2008. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 52:708-714
16. Gao, L., Y. Li, H. D. Schultz, W. Z. Wang, W. Wang, M. Finch, et al. 2010. Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 298:H945-H955
17. Grobe, J. L., A. P. Mecca, M. Lingis, V. Shenoy, T. A. Bolton, J. M. Machado, et al. 2007. Prevention of angiotensin IIinduced cardiac remodeling by angiotensin-(1-7). Am. J. Physiol. Heart Circ. Physiol. 292:H736-H742
18. Guyenet, P. G. 2006. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7:335-346
19. Han, Y., Y. Zhang, H. J. Wang, X. Y. Gao, W. Wang, and G. Q. Zhu. 2005. Reactive oxygen species in paraventricular nucleus modulates cardiac sympathetic afferent reflex in rats. Brain Res. 1058:82-90.
20. van. Heerebeek, L., A. Borbely, H. W. Niessen, J. G. Bronzwaer, J. van der Velden, G. J. Stienen, et al. 2006. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113:1966-1973
21. Hirooka, Y., T. Kishi, K. Ito, and K. Sunagawa. 2013. Potential clinical application of recently discovered brain mechanisms involved in hypertension. Hypertension 62:995-1002
22. Honda, N., Y. Hirooka, K. Ito, R. Matsukawa, K. Shinohara, T. Kishi, et al. 2013. Moxonidine-induced central sympathoinhibition improves prognosis in rats with hypertensive heart failure. J. Hypertens. 31:2300-2308
23. Huang, B. S., M. Ahmad, J. Tan, and F. H. Leenen. 2009. Chronic central versus systemic blockade of AT(1) receptors and cardiac dysfunction in rats post-myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 297:H968-H975
24. Huang, B. S., S. Ahmadi, M. Ahmad, R. A. White, and F. H. Leenen. 2010. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-”ouabain” pathway. Am. J. Physiol. Heart Circ. Physiol. 299:H422-H430
25. Ito, S., and A. F. Sved. 1996. Blockade of angiotensin receptors in rat rostral ventrolateral medulla removes excitatory vasomotor tone. Am. J. Physiol. 270:R1317-R1323
26. Ito, K., Y. Hirooka, R. Matsukawa, M. Nakano, and K. Sunagawa. 2012. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. Cardiovasc. Res. 93:33-40
27. Johnson, A. K., and P. M. Gross. 1993. Sensory circumventricular organs and brain homeostatic pathways. FASEB 7:678-686
28. Kang, Y. M., Y. Ma, C. Elks, J. P. Zheng, Z. M. Yang, and J. Francis. 2008. Cross-talk between cytokines and reninangiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc. Res. 79:671-678
29. Kang, Y. M., R. L. He, L. M. Yang, D. N. Qin, A. Guggilam, C. Elks, et al. 2009. Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc. Res. 83:737-746
30. Kimura, Y., Y. Hirooka, Y. Sagara, K. Ito, T. Kishi, H. Shimokawa, et al. 2005. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ. Res. 96:252-260
31. Kishi, T., Y. Hirooka, Y. Kimura, K. Ito, H. Shimokawa, and A. Takeshita. 2004. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109:2357-2362
32. Kishi, T., Y. Hirooka, S. Konno, K. Ogawa, and K. Sunagawa. 2010. Angiotensin II type 1 receptor-activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 55:291-297
33. Kishi, T., Y. Hirooka, K. Ogawa, S. Konno, and K. Sunagawa. 2011. Calorie restriction inhibits sympathetic nerve activity via anti-oxidant effect in the rostral ventrolateral medulla of obesity-induced hypertensive rats. Clin. Exp. Hypertens. 33:240-245
34. Kishi, T., Y. Hirooka, and K. Sunagawa. 2012. Sympathoinhibition caused by orally administered telmisartan through inhibition of the AT(1) receptor in the rostral ventrolateral medulla of hypertensive rats. Hypertens. Res. 35:940-946
35. Kishi, T., Y. Hirooka, and K. Sunagawa. 2014. Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure. Am. J. Hypertens. 27:260-267
36. Kleiber, A. C., H. Zheng, N. M. Sharma, and K. P. Patel. 2010. Chronic AT1 receptor blockade normalizes NMDAmediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure. Am. J. Physiol. Heart Circ. Physiol. 298:H1546-H1555
37. Koga, Y., Y. Hirooka, S. Araki, M. Nozoe, T. Kishi, and K. Sunagawa. 2008. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens. Res. 31:2075-2083
38. Leenen, F. H. 2007. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ. Res. 101:221-223
39. Leenen, F. H. 2014. Actions of Circulating Angiotensin II and Aldosterone in the Brain Contributing to Hypertension. Am. J. Hypertens. 27:1024-1032
40. Leenen, F. H., V. Skarda, B. Yuan, and R. White. 1999a. Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am. J. Physiol. 276:H317-H325
41. Leenen, F. H., B. Yuan, and B. S. Huang. 1999b. Brain “ouabain” and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am. J. Physiol. 277: H1786-H1792
42. Levick, S. P., D. B. Murray, J. S. Janicki, and G. L. Brower. 2010. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 55:270-276
43. Li, Q., W. E. Dale, E. M. Hasser, and E. H. Blaine. 1996. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am. J. Physiol. 271:R200-R207
44. Lindley, T. E., D. W. Infanger, M. Rishniw, Y. Zhou, M. F. Doobay, R. V. Sharma, et al. 2009. Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:R1-R8
45. Lob, H. E., D. Schultz, P. J. Marvar, R. L. Davisson, and D. G. Harrison. 2010. Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension 61:382-387
46. Malpas, S. C. 2010. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol. Rev. 90:513-557
47. Marx, S. O., S. Reiken, Y. Hisamatsu, T. Jayaraman, D. Burkhoff, N. Rosemblit, et al. 2000. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101:365-376.
48. McKinley, M. J., A. L. Albiston, A. M. Allen, M. L. Mathai, C. N. May, R. M. McAllen, et al. 2003. The brain reninangiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 35:901-918
49. Nishihara, M., Y. Hirooka, R. Matsukawa, T. Kishi, and K. Sunagawa. 2012a. Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J. Hypertens. 30:97-106
50. Nishihara, M., Y. Hirooka, T. Kishi, and K. Sunagawa. 2012b. Different role of oxidative stress in paraventricular nucleus and rostral ventrolateral medulla in cardiovascular regulation in awake spontaneously hypertensive rats. J. Hypertens. 30:1758-1765
51. Nozoe, M., Y. Hirooka, Y. Koga, S. Araki, S. Konno, T. Kishi, et al. 2008. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J. Hypertens. 26:2176-2184
52. Ogawa, K., Y. Hirooka, T. Kishi, T. Ide, and K. Sunagawa. 2013. Partially silencing brain toll-like receptor 4 prevents in part left ventricular remodeling with sympathoinhibition in rats with myocardial infarction-induced heart failure. PLoS ONE 8:e69053
53. Pacher, P., T. Nagayama, P. Mukhopadhyay, S. Batkai, and D. A. Kass. 2008. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 3:1422-1434
54. Roig, E., F. Perez-Villa, M. Morales, W. Jimenez, J. Orus, M. Heras, et al. 2000. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur. Heart J. 21:53-57
55. Schraeger, J. A., C. A. Canby, B. J. Rongish, M. Kawai, and R. J. Tomanek. 1994. Normal left ventricular diastolic compliance after regression of hypertrophy. J. Cardiovasc. Pharmacol. 23:349-357
56. Schunkert, H., S. S. Tang, S. E. Litwin, D. Diamant, G. Riegger, V. J. Dzau, et al. 1993. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc. Res. 27:731-735
57. Simon, G., G. Abraham, and G. Cserep. 1995. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am. J. Hypertens. 8:645-650
58. Sun, C., K. W. Sellers, C. Sumners, and M. K. Raizada. 2005. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ. Res. 96:659-666
59. Tagawa, T., and R. A. L. Dampney. 1999. AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. Hypertension 34:1301-1307
60. Timmermans, P. B., P. C. Wong, A. T. Chiu, W. F. Herblin, P. Benfield, D. J. Carini, et al. 1993. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:205-251
61. Triposkiadis, F., G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas, and J. Butler. 2009. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J. Am. Coll. Cardiol. 54:1747-1762
62. Wei, S. G., Y. Yu, Z. H. Zhang, R. M. Weiss, and R. B. Felder. 2008. Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52:679-686
63. Wright, J. W., K. A. Roberts, L. A. Stubley, J. M. Hanesworth, and J. W. Harding. 1993. Hypothalamic angiotensin release in response to AII or glutamic acid stimulation of the SFO in rats. Brain Res. Bull. 31:649-654
64. Zhang, W., B. S. Huang, and F. H. Leenen. 1999. Brain reninangiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am. J. Physiol. 276:H1608-H1615
65. Zucker, I. H., L. Xiao, and K. K. Haack. 2014. The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure. Clin. Sci. (Lond.) 126:695-706.